Patents Assigned to The University of Erlangen
  • Sulfoglycolipid antigens, their extraction from , and their use against tuberculosis
    Patent number: 8153610
    Abstract: The present invention relates to compounds of the following general formula: (I) wherein R1 and R2 are fatty acyl groups, a process to extract them from Mycobacterium tuberculosis, and their use in the treatment or the prophylaxis of tuberculosis.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: April 10, 2012
    Assignees: Centre National de la Recherche Scientifique (C.N.R.S.), University Hospital of Basel, University of Erlangen
    Inventors: Germain Puzo, Martine Gilleron, Steffen Stenger, Gennaro De Libero
  • Formulation comprising bioactive agents and method of using same
    Patent number: 7897174
    Abstract: Disclosed are methods of making BMP-2 microparticles and methods of using the microparticles. These microparticles are prepared, for example, by mixing a solution containing BMP-2 with a second solution whose ionic concentration and pH results in the precipitation of the BMP-2.
    Type: Grant
    Filed: February 10, 2003
    Date of Patent: March 1, 2011
    Assignees: University of Erlangen-Nurnberg, Wyeth Inc.
    Inventors: Susan J. Sofia, Daniel Schwartz, Wolfgang Friess
  • Method and apparatus for determining the shape and the local surface normals of specular surfaces
    Patent number: 7532333
    Abstract: A method teaches how to measure—even strongly curved—specular surfaces with an apparatus that measures a shape as well as local surface normals absolutely. This is achieved by the observation and evaluation of patterns that are reflected at the surface. The reflected patterns are observed from different directions. The evaluation is done by termination of those locations in space, where the surface normals that are observed from different directions, have at least deviations against each other.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: May 12, 2009
    Assignees: 3D-Shape GmbH, The University of Erlangen
    Inventors: Gerd Haeusler, Markus Knauer, Ralf Lampalzer
  • Combined immunological agent and sensitizing agent for the treatment of cancer
    Publication number: 20080267977
    Abstract: A method and kit for inhibiting the proliferation of cancer cells are disclosed, based on a combination of an apoptosis-inducing immunologic agent, and a sensitizing agent. When used in cancer therapy, the two agents in combination enhance the anti-cancer treatment efficacy obtained with the immunologic agent or the sensitizing agent alone, by a supraadditive amount.
    Type: Application
    Filed: April 26, 2007
    Publication date: October 30, 2008
    Applicant: Friedrich-Alexander University of Erlangen-Nuremberg
    Inventors: Georg H.M. Fey, Julia Stieglmaier, Michael Schwenkert, Michael Schwemmlein